PTHS Pelthos Therapeutics Inc.

Fundamentals / CIK 0001919246 / USD

Pelthos Therapeutics Inc. reported $51.29M in revenue and a net loss of $78.05M for the trailing twelve months ended September 30, 2026 (up 107.9% year over year), with a 83.2% gross margin and a -101.6% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PTHS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

4 fiscal years (2022 to 2025), reported in USD.

$21.13M$10.56M$0-$41.93MFY 2022 Net Income: -$2.46M2022FY 2023 Net Income: -$7.38M2023FY 2024 Revenue: $0FY 2024 Net Income: -$7.96M2024FY 2025 Revenue: $16.80MFY 2025 Net Income: -$43.32M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31
Revenue $16.80M $0 -- --
Cost of Revenue $3.99M $0 -- --
Gross Profit $12.81M $0 -- --
Research & Development $1.23M $1.18M $2.58M $392K
Selling, General & Admin $42.45M $6.39M -- --
Total Operating Expenses -- $7.57M $6.86M $2.32M
Operating Income -$32.43M -$7.57M -$6.86M -$2.32M
EBITDA -$30.14M -$6.12M -- --
Interest Expense $3.01M $786K $309K $136K
Income Before Tax -$50.71M -$7.96M -$7.38M -$2.46M
Income Tax Expense -$7.39M $0 -- --
Net Income -$43.32M -$7.96M -$7.38M -$2.46M
Basic EPS -$230.40 -$142.70 -$5,254.55 $5,136.36
Diluted EPS -$230.40 -$142.70 -$5,254.55 --
Basic Shares Outstanding 188.1K 55.7K 1.4K 479
Diluted Shares Outstanding 188.1K 55.7K 1.4K --

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $15.39M $15.60M $10.91M $9.39M $7.41M $0 $0 --
Cost of Revenue $1.66M $3.61M $1.67M $1.67M $2.32M $0 $0 --
Gross Profit $13.73M $11.99M $9.23M $7.72M $5.09M $0 $0 --
Research & Development $1.02M $600K $186K $374K $145K $515K $194K $285K
Selling, General & Admin $18.84M $27.67M $21.10M $19.71M $18.38M $2.72M $1.64M --
Total Operating Expenses -- -- -- -- $22.77M $3.23M $1.83M $1.82M
Operating Income -$9.69M -$17.32M -$13.09M -$12.00M -$15.36M -$3.23M -$1.83M -$1.82M
EBITDA -$8.36M -$16.00M -$11.59M -$10.79M -$14.29M -$2.89M -$1.43M --
Interest Expense $2.27M $2.39M $2.35M $1.31M $1.35M $218K $1.8K $0
Income Before Tax -$7.89M -$23.42M -$10.24M -$28.59M -$16.70M -$3.45M -$1.97M -$1.93M
Income Tax Expense $0 $0 $0 -$6.92M -$465K $0 $0 --
Net Income -$7.89M -$23.42M -$25.07M -$21.66M -$16.24M -$3.45M -$1.97M -$1.93M
Basic EPS -$2.04 -$66.20 -$30.90 -- -$5.30 -$52.90 -$32.10 --
Diluted EPS -$2.04 -$66.20 -$30.90 -- -$5.30 -$52.90 -$32.10 --
Basic Shares Outstanding 3.9M 353.9K 331.2K -- 3.1M 65.2K 61.3K --
Diluted Shares Outstanding 3.9M 353.9K 331.2K -- 3.1M 65.2K 61.3K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $17.97M $513K $100K $100K
Cash & Short-Term Investments $17.97M $513K $100K $100K
Accounts Receivable, Net $8.86M $0 -- --
Inventory $23.57M $0 -- --
Other Current Assets -- $106K -- --
Total Current Assets $53.41M $1.37M $96K $55K
Property, Plant & Equipment, Net $9.59M $0 -- --
Goodwill $24.68M $0 -- --
Intangible Assets $39.47M $0 -- --
Other Non-Current Assets $0 -- -- --
Total Non-Current Assets $76.99M $0 $0 $0
Total Assets $130.4M $1.37M $96K $55K
Accounts Payable $2.99M $1.90M -- --
Deferred Revenue (Current) $966K $0 -- --
Other Current Liabilities $3.84M $0 -- --
Total Current Liabilities $25.99M $4.08M $6.54M $3.76M
Deferred Revenue (Non-Current) $1.28M $0 -- --
Other Non-Current Liabilities $30.05M $0 -- --
Total Non-Current Liabilities $65.52M $0 $0 $0
Total Liabilities $91.52M $4.08M $6.54M $3.76M
Total Debt (incl. Leases) $3.39M -- -- --
Common Stock $0 $0 $391 $111
Retained Earnings -$64.79M -$21.48M -$13.52M -$6.14M
Accumulated Other Comp. Income $0 -- -- --
Total Stockholders' Equity $38.88M -$2.71M -$6.45M -$3.71M
Total Equity $38.88M -$2.71M -$6.45M -$3.71M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $17.69M $24.19M $31.98M $17.97M $14.20M $59K $131K $513K
Cash & Short-Term Investments $17.69M $24.19M $31.98M $17.97M $14.20M $59K $131K $513K
Accounts Receivable, Net $13.41M $14.48M $11.70M $8.86M -- -- -- $0
Inventory $21.47M $21.47M $23.42M $23.57M $24.10M -- -- $0
Other Current Assets -- -- -- -- $574K -- -- $106K
Total Current Assets $56.07M $63.36M $69.80M $53.41M $49.76M $823K $911K $1.37M
Property, Plant & Equipment, Net $8.51M $8.88M $9.31M $9.59M $10.17M -- -- $0
Goodwill $24.68M $24.68M $24.68M $24.68M $30.62M -- -- $0
Intangible Assets $36.34M $37.40M $38.44M $39.47M $32.52M -- -- $0
Other Non-Current Assets $281K -- -- $0 -- -- -- --
Total Non-Current Assets $72.75M $74.00M $75.58M $76.99M $76.67M $0 $0 $0
Total Assets $128.8M $137.4M $145.4M $130.4M $126.4M $823K $911K $1.37M
Accounts Payable $3.72M $5.85M $6.15M $2.99M $5.67M -- -- $1.90M
Deferred Revenue (Current) $729K $729K $978K $966K $1.02M -- -- $0
Other Current Liabilities -- -- $3.40M $3.84M $5.56M -- -- $0
Total Current Liabilities $31.43M $31.96M $25.00M $25.99M $24.77M $7.32M $5.11M $4.08M
Deferred Revenue (Non-Current) $911K $1.09M $1.03M $1.28M -- -- -- $0
Other Non-Current Liabilities -- -- $31.95M $30.05M $26.18M -- -- $0
Total Non-Current Liabilities $103.6M $106.9M $85.27M $65.52M $43.41M $0 $0 $0
Total Liabilities $135.0M $138.9M $110.3M $91.52M $68.18M $7.32M $5.11M $4.08M
Total Debt (incl. Leases) $3.10M $3.19M $3.29M $3.39M $2.85M -- -- --
Common Stock $0 $0 $0 $0 -- $67 $621 $0
Retained Earnings -$121.2M -$113.3M -$75.03M -$64.79M -$43.13M -$26.89M -$23.44M -$21.48M
Accumulated Other Comp. Income $3.32M $2.08M $3.19M $0 -- -- -- --
Total Stockholders' Equity -$6.19M -$1.50M $19.27M $38.88M $58.25M -$6.50M -$4.20M -$2.71M
Total Equity -$6.19M -$1.50M $19.27M $38.88M $58.25M -$6.50M -$4.20M -$2.71M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$43.32M -$7.96M -$7.38M -$2.46M
Depreciation & Amortization $2.29M $1.46M -- --
Stock-Based Compensation $5.46M $1.80M $1.73M $110K
Change in Receivables -$8.81M $0 -- --
Change in Inventory $1.78M $0 -- --
Change in Payables $1.36M $1.18M -- --
Operating Cash Flow -$22.59M -$5.79M -$981K -$1.57M
Capital Expenditure -$99K $0 -- --
Free Cash Flow -$22.69M -$5.79M -- --
Investing Cash Flow -$5.24M $0 -- --
Common Stock Issued $0 $5.97M $255K --
Share Repurchases $0 -$75K -- --
Financing Cash Flow $45.34M $6.21M $1.02M $1.62M
Net Change in Cash $17.51M $417K $41K $55K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$7.89M -$23.42M -$25.07M -$21.66M -$16.24M -$3.45M -$1.97M -$1.93M
Depreciation & Amortization $1.34M $1.32M $1.50M $1.22M $1.07M $342K $404K --
Stock-Based Compensation $1.94M $2.76M $1.91M $1.80M $2.76M $413K $486K $530K
Change in Receivables $1.07M -$2.78M -$2.84M -$870K -$7.94M $0 $0 --
Change in Inventory $203K $1.22M $156K $393K $1.39M $0 $0 --
Change in Payables -$2.19M -$338K $3.16M -$2.67M $928K $2.40M $707K --
Operating Cash Flow -$5.16M -$7.66M -$13.13M -$6.25M -$15.26M -$447K -$632K -$670K
Capital Expenditure -$60K -$2.0K -$194K -$99K $0 $0 $0 --
Free Cash Flow -$5.22M -$7.67M -$13.32M -$6.35M -$15.26M -$447K -$632K --
Investing Cash Flow -$60K -$2.0K -$194K -$8.00M $2.76M $0 $0 --
Common Stock Issued -- -- -- -- -- -- -- $0
Share Repurchases -- -- -- -- -- -- -- $74K
Financing Cash Flow -$1.17M $0 $27.52M $18.02M $26.69M $375K $250K -$72K
Net Change in Cash -$6.40M -$7.67M $14.20M $3.77M $14.19M -$72K -$382K -$742K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 76.3% -- -- --
Operating Margin -193.1% -- -- --
Net Profit Margin -257.9% -- -- --
Return on Equity (ROE) -111.4% -- -- --
Return on Assets (ROA) -33.2% -581.1% -7657.1% -4464.2%
Current Ratio 2.05x 0.34x 0.01x 0.01x
Quick Ratio 1.15x 0.34x 0.02x 0.03x
Debt to Equity 0.09x -- -- --
EPS Growth (YoY) -- -- -202.3% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 83.2% 78.6% 79.6% 76.3% -- -- -- --
Operating Margin -101.6% -133.4% -157.7% -193.1% -- -- -- --
Net Profit Margin -152.2% -199.5% -239.8% -257.9% -- -- -- --
Return on Equity (ROE) -- -- -344.8% -111.4% -40.5% -- -- --
Return on Assets (ROA) -60.6% -62.9% -45.7% -33.2% -18.7% -1098.4% -807.9% -581.1%
Current Ratio 1.78x 1.98x 2.79x 2.05x 2.01x 0.11x 0.18x 0.34x
Quick Ratio 1.10x 1.31x 1.86x 1.15x 1.04x 0.01x 0.03x 0.34x
Debt to Equity -- -- 0.17x 0.09x 0.05x -- -- --
Revenue Growth (YoY) +107.9% -- -- -- -- -- -- --
Gross Profit Growth (YoY) +169.8% -- -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001919246) · from December 31, 2022 Data through September 30, 2026 · synced Nov 21, 2026, 05:01 UTC · Open in terminal